Expression of Herpes Simplex Virus 1 Glycoprotein B in Human Cells and Protection of Mice against Lethal Herpes Simplex Virus 1 Infection

  • Roberto Manservigi
  • Massimo Negrini
  • Rita Gualandri
  • Gabriele Milanesi
  • Giuseppe Barbanti-Brodano
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 257)


Expression of cloned viral and cellular genes in eukaryotic cells is relevant to production of vaccines (Melnick, 1986; Moss and Flexner, 1987) and gene therapy (Anderson, 1984). To this purpose numerous eukaryotic vectors have been developed. Since the level of expression of exogenous genes is directly related to the degree of gene amplification (Rigby, 1983) episomal eukaryotic vectors have been constructed where a viral origin of replication directs vector amplification in suitable cells (DiMaio, 1987; Milanesi et al., 1984). However, only two eukaryotic vectors (Milanesi et al., 1984; Sugden et al., 1985) are specific for human cells and they allow expression of genes endowed with their own regulatory sequences. We have therefore devised a viral vector (pBK-1) that replicates and persists episomally in human cells; The structure and general characteristics of this vector have been described in detail (Milanesi et al., 1984). It contains DNA sequences from the plasmid pML, a deletion derivative of pBR322, as well as the origin of replication and the early region of BK virus (BKV), a human papovavirus that efficently replicates in human cells.


Herpes Simplex Virus Type North Atlantic Treaty Organization Vector Copy Number Herpes Simplex Virus Glycoprotein Eukaryotic Vector 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. AHMED ALI, M., BUTCHER, M., and GHOSH, H.P., 1987, Expression and nuclear envelope localization of biologically active fusion glycoprotein gB of herpes simplex virus in mammalian cells using cloned DNA. Proc. Natl. Acad. Sci. USA, 84:5675.CrossRefGoogle Scholar
  2. ANDERSON, W.F., 1984, Prospects for human gene therapy. Science, 226:401.PubMedCrossRefGoogle Scholar
  3. ARSENAKIS, M., HUBENTHAL-VOSS, J., CAMPADELLI-FIUME, G., PEREIRA, L., and ROIZMAN, B., 1986, Construction and properties of a cell line constitutively expressing the herpes simplex virus glycopretein B dependent on functional 4 protein synthesis, J. Virol., 60:674.PubMedGoogle Scholar
  4. BALACHANDRAN, N., BACCHETTI, S., and RAWLS, W.E., 1982, Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect. Immun. ,37: 1132.PubMedGoogle Scholar
  5. BZIK, D.J., FOX, B.A., DeLUCA, N.A., and PERSON, S., 1984, Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology, 133:301.PubMedCrossRefGoogle Scholar
  6. CAMPADELLI-FIUME, G., and SERAFIN1-CESSI, F., 1985, Processing of the oligosaccharide chains of herpes simplex virus type 1 glycoproteins. In : “The Herpesviruses”, Vol. 3, B. Roizman, ed., Plenum Press, New York.Google Scholar
  7. CANTIN, E.M., EBERLE, R., BALDICK, J.L., MOSS, B., WILLEY, D.E., NOTKINS, A.L., and OPENSHAW, H., 1987, Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc. Natl. Acad. Sci. USA, 84:5908.PubMedCrossRefGoogle Scholar
  8. CORALLINI, A., PAGNANI, M., VIADANA, P., SILINI, E., MOTTES, M., MILANESI, G., GERNA, G., VETTOR, R., TRAPELLA, G., SILVANI, V., GAIST, G., and BARBANTI-BRODANO, G., 1987, Association of BK virus with human brain tumors and tumors of pancreatic islets. Int. J. Cancer, 39:60.PubMedCrossRefGoogle Scholar
  9. DiMAIO, D., TREISMAN, R., and MANIATIS, T., 1982, Bovine papillomavirus vector that propagates as a plasmid in both mouse and bacterial cells. Proc. Natl. Acad. Sci. USA, 79:4030,PubMedCrossRefGoogle Scholar
  10. GRAHAM, F.L., and van der EB, A.J., 1973, A new technique for the assay of infectivity of huamn adenovirus 5 DNA. Virology, 52:456.PubMedCrossRefGoogle Scholar
  11. GRAHAM, F.L., SMILEY, J., RUSSEL, W.C., and NAIRN, R., 1977, Characteristics of a human cell line transformed by DNA from adenovirus type 5. J. Gen. Virol., 36:59.PubMedCrossRefGoogle Scholar
  12. HSlUNG, N., FITTS, R., WILSON, S., MILNE, A., and HAMER, D., 1984, Efficient production of hepatitis B surface antigen using a bovine papilloma virus-metallothionein vector. J. Mol. Appl. Genet., 2:497.Google Scholar
  13. KINO, Y., ETO, T., OHTOMO, N., HAYASHI, Y., YAMAMOTO, M., and MORI, R., 1985, Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus. Microbiol. Immunol., 29:143.PubMedGoogle Scholar
  14. KITAMURA, K., NAMAZUE, J., CAMPO-VERA, H., OGINO, T., and YAMANISHI, K., 1986, Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. Virology, 149: 74.PubMedCrossRefGoogle Scholar
  15. LITTLE, S.P., JOFRE, J.T., COURTNEY, R.J., and SCHAFFER, P.A., 1981, A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1. Virology, 115:149.PubMedCrossRefGoogle Scholar
  16. MELNICK, J.L., 1986, Virus vaccines: 1986 update. Prog. Med. Virol., 33:134.PubMedGoogle Scholar
  17. MOSS, B., AND FLEXNER, C, 1987, Vaccinia virus expression vectors. Annu. Rev. Immunol., 5:305.PubMedCrossRefGoogle Scholar
  18. MILANESI, G., BARBANTI-BRODANO, G., NEGRINI, M., LEE, D., CORALLINI, A., CAPUTO, A., GROSSI, M.P., and RICCIARDI, R.P., 1984, BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli. Mol. Cell. Biol., 4:1551.PubMedGoogle Scholar
  19. NORRILD, B., 1980, Immunochemistry of herpes simplex virus glycoproteins. Curr. Top. Microbiol. Immunol., 90:67.PubMedCrossRefGoogle Scholar
  20. NORRILD, B., SHORE, S.L., and NAHMIAS, A.J., 1979, Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides. J. Virol., 32:741.PubMedGoogle Scholar
  21. NOZAKI, C, MAKIZUMI, K., KINO, Y., NAKATAKE, H., ETO, T., MIZUNO, K., HAMADA, F., and OHTOMO, N., 1985, Expression of herpes simplex virus glycoprotein B gene in yeast. Virus Research, 4:107.PubMedCrossRefGoogle Scholar
  22. PACHL, C, BURKE, R.L., STUVE, L.L., SANCHEZ-PESCADOR, L., VAN NEST, G., MASIARZ, F., and DINA, D., 1987, Expression of cell-associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells. J. Virol., 61:315.PubMedGoogle Scholar
  23. RECTOR, J.T., LAUSCH, R.N., and OAKES, J.E., 1982, Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infect. Immun., 38:168.PubMedGoogle Scholar
  24. RIGBY, P.W.J., 1983, Cloning vectors derived from animal viruses. J. Gen. Virol., 64:255.PubMedCrossRefGoogle Scholar
  25. SOUTHERN, P.J., and BERG, P., 1982, Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet., 1:327.PubMedGoogle Scholar
  26. SUGDEN, B., MARSH, K., AND YATES, J., 1985, A vector that replicates as a plasmid and can be efficiently selected in B-limphoblasts transformed by Epstein-Barr virus. Mol. Cell. Biol., 5:410.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Roberto Manservigi
    • 1
  • Massimo Negrini
    • 1
  • Rita Gualandri
    • 1
  • Gabriele Milanesi
    • 2
  • Giuseppe Barbanti-Brodano
    • 1
  1. 1.Institute of MicrobiologyUniversity of FerraraFerraraItaly
  2. 2.Institute of Istology and EmbriologyUniversity of FerraraFerraraItaly

Personalised recommendations